title: Stimulatory effect of PGF2α on PRL based on experimental inhibition of each hormone in mares.
abstract: During the luteolytic period in mares, the peak of 65% of pulses of a PGF2α metabolite (PGFM) and the peak of a pulse of PRL have been reported to occur at the same hour. It is unknown whether the synchrony reflects an effect of PGF2α on PRL or vice versa. Controls, a flunixin meglumine (FM)-treated group (to inhibit PGF2α), and a bromocriptine-treated group (to inhibit PRL), were used at 14 days postovulation in June and in September (n = 6 mares/group/mo). Blood samples were collected hourly from just before treatment (Hour 0) to Hour 10. Concentrations of PGFM in the FM group were lower (P < 0.05) at Hours 4 to 6 than in the controls in each month, but bromocriptine had no detected effects on PGFM. Concentrations of PGFM averaged over all groups and within each group did not differ between June and September. Compared to the controls, concentrations of PRL in June were lower (P < 0.05) in the FM group at Hours 4 to 8 and in the bromocriptine group at Hours 4 to 10. Concentration of PRL averaged over groups was lower (P < 0.0001) in September (0.9 ± 0.05 ng/mL, mean ± SEM) than in June (3.0 ± 0.3 ng/mL). Results supported the hypothesis that the positive association between PGFM and PRL concentrations in mares represents an effect of PGF2α on PRL rather than an effect of PRL on PGF2α.
authors.affiliation: Eutheria Foundation, Cross Plains, Wisconsin, USA. ginther@vetmed.wisc.edu
authors.forename: O J
authors.initials: OJ
authors.lastname: Ginther
authors.forename: F L V
authors.initials: FL
authors.lastname: Pinaffi
authors.forename: M B
authors.initials: MB
authors.lastname: Rodriguez
authors.forename: L F
authors.initials: LF
authors.lastname: Duarte
authors.forename: M A
authors.initials: MA
authors.lastname: Beg
mesh_terms: D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology*; D003002:Clonixin / Q000031:analogs & derivatives* / Q000494:pharmacology; D015237:Dinoprost / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006727:Hormone Antagonists / Q000494:pharmacology; D006736:Horses / Q000502:physiology*; D011388:Prolactin / Q000037:antagonists & inhibitors*; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D012621:Seasons
chemical_list: D006727:Hormone Antagonists; D011448:Prostaglandin Antagonists; D001971:Bromocriptine; C014558:flunixin meglumine; D011388:Prolactin; D015237:Dinoprost; D003002:Clonixin